SP

Subramania Pillai Madhu Mathi

Active Director Partner DIN 09394716
DIN 09394716 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Subramania Pillai Madhu Mathi

Data last updated:

Subramania Pillai Madhu Mathi is a Partner at Bonn Stering Bio Science Llp (since 2021). The company operates in Pharma.

DIN 09394716
Primary Designation Partner
Industry Pharma
First Appointment 18 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner18 Nov 20212021Active

Board colleagues of Subramania Pillai Madhu Mathi

Directorship timeline

Open interactive timeline →
Bonn Stering Bio Science Llp
Premium access

Shareholding and investment profile for Subramania Pillai Madhu Mathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramania Pillai Madhu Mathi

Subramania Pillai Madhu Mathi currently holds 1 directorship: Bonn Stering Bio Science Llp (Partner, since 18 Nov 2021).

Subramania Pillai Madhu Mathi was first appointed on 18 Nov 2021 as Partner at Bonn Stering Bio Science Llp.

The current boards of Subramania Pillai Madhu Mathi's companies include Bharathidhasan (Bonn Stering Bio Science Llp), Rada Ragunathan (Bonn Stering Bio Science Llp), Raghunaathan Ramaswamy (Bonn Stering Bio Science Llp), Umarani (Bonn Stering Bio Science Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available